Daiwa Securities Group Inc. Biotechnology

Daiwa Securities Group Inc.

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
SANA Sana Biotechnology, Inc.	$926M	$1,000 0.0% of portfolio	767	Q4 2022 Added 39.2%
STOK Stoke Therapeutics, Inc.	$535M	$1,000 0.0% of portfolio	175	Q4 2024 New
TSHA Taysha Gene Therapies, Inc.	$126M	$1,000 0.0% of portfolio	691	Q1 2024 New
THRD Third Harmonic Bio, Inc.	$219M	$1,000 0.0% of portfolio	149	Q1 2024 New
VNDA Vanda Pharmaceuticals Inc.	$266M	$1,000 0.0% of portfolio	191	Q3 2021 Added 59.17%
VYGR Voyager Therapeutics, Inc.	$122M	$1,000 0.0% of portfolio	201	Q1 2024 New
YMAB Y M Abs Therapeutics, Inc.	$193M	$1,000 0.0% of portfolio	162	Q1 2024 New
KMPH Kempharm, Inc	$170M	$1,000 0.0% of portfolio	182	Q1 2025 New
ALEC Alector, Inc.	$142M	$0 0.0% of portfolio	277	Q3 2021 Added 85.91%
BMEA Biomea Fusion, Inc.	$53.3M	$0 0.0% of portfolio	109	Q2 2022 New
EDIT Editas Medicine, Inc.	$231M	$0 0.0% of portfolio	277	Q2 2024 Reduced 96.15%
LYEL Lyell Immunopharma, Inc.	$2.55B	$0 0.0% of portfolio	917	Q2 2022 Added 30.63%
MGNX Macrogenics Inc	$94.6M	$0 0.0% of portfolio	209	Q3 2021 Added 97.17%
PLRX Pliant Therapeutics, Inc.	$76.4M	$0 0.0% of portfolio	196	Q4 2022 Added 59.35%
TNGX Tango Therapeutics, Inc.	$588M	$0 0.0% of portfolio	355	Q4 2022 New
TERN Terns Pharmaceuticals, Inc.	$216M	$0 0.0% of portfolio	151	Q4 2022 New

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.